Pre-Clinical Imaging (In Vivo) Market to Grow at a CAGR of 14.5% & to Reach $1.55 Billion By 2017 - New Report by MarketsandMarkets

[270 Pages Report] Pre-Clinical Molecular Imaging (In Vivo) Market report includes various standalone and multi-modality technologies along with the reagents used under each modality.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
MarketsandMarkets

MarketsandMarkets

The key players in this market are Siemens AG (Germany), PerkinElmer, Inc. (U.S.), Bruker Corporation (U.S.), Bioscan, Inc. (U.S.), Mediso Medical Imaging Systems (Hungary), Gamma Medica (U.S.) & few more.

(PRWEB) February 27, 2013

The report "Global Pre-Clinical Imaging (In vivo) Market By systems and reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT Multimodality/Hybrid Imaging Modalities] - Competitive Analysis Global Forecasts to 2017"- analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.

Browse

  • 117 Market Data Tables
  • 20 Figures
  • 270 pages and an in-depth Table of Content on

Pre-Clinical Imaging (In Vivo) Market By Systems and Reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT & Multimodality/Hybrid Imaging Modalities]

Buy a copy of this report @ http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=841

Early buyers will receive 10% customization on this report.

The global pre-clinical imaging (in vivo) market is broadly segmented into two categories, namely, Imaging systems and Imaging reagents. This market is expected to grow at a CAGR of 14.5% from 2012 to 2017.

  • Imaging systems can be divided into stand alone imaging systems and multimodal imaging systems. Stand alone imaging systems are further classified into nuclear imaging, optical imaging, Micro-MRI, Micro-CT and Micro-Ultrasound. Multimodal imaging systems are classified into multimodal nuclear imaging devices and multimodal optical imaging devices.
  • Imaging reagents can be divided into nuclear imaging agents, optical imaging agents, MRI contrasting reagents, CT contrast reagents and ultrasound contrast reagents.

The global market has witnessed challenging and dynamic market conditions over the last couple of years, and is valued at $789.4 million in 2012 with an estimated annual growth rate of 14.5% over the next five years. Pre-Clinical in vivo imaging industry has experienced myriad technological advancements, changes in market due to industry consolidation, and changes in government funding and support for research studies across the global over the past decade. It is expected that the trend of product development and modification will continue in future to solve the present challenges and unmet needs of the market.

Market displays growing preference for hybrid technologies such as SPECT+CT and PET + CT. This trend is expected for novel combination systems such as SPECT + MRI and PET + MRI. The global pre-clinical imaging (in vivo) market is expected to show growth over the long term due to driving factors such as technological advancements, growing adoption rate for pre-clinical imaging, rising application of functional imaging and increasing number of pharma companies and research institutions.

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales(at)marketsandmarkets(dot)com
Visit our Google Plus Profile
Connect with us on LinkedIn
Connect with us on Facebook


Contact

Follow us on: Contact's Facebook Contact's Twitter Contact's LinkedIn